3Chopt Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
9,420
-1,047
-10% -$27.4K 0.04% 230
2026
Q1
$294K Buy
10,467
+1,706
+19% +$45.4K 0.07% 176
2025
Q4
$218K Sell
8,761
-1,271
-13% -$32.1K 0.05% 203
2025
Q3
$256K Buy
10,032
+1,692
+20% +$41.8K 0.06% 192
2025
Q2
$202K Buy
8,340
+389
+5% +$9.07K 0.05% 213
2025
Q1
$201K Sell
7,951
-2,246
-22% -$58.8K 0.05% 204
2024
Q4
$271K Sell
10,197
-12,122
-54% -$329K 0.09% 74
2024
Q3
$646K Sell
22,319
-448
-2% -$13.1K 0.23% 66
2024
Q2
$637K Buy
22,767
+11,265
+98% +$310K 0.19% 100
2024
Q1
$319K Sell
11,502
-564
-5% -$15.7K 0.13% 67
2023
Q4
$347K Sell
12,066
-27,604
-70% -$834K 0.13% 133
2023
Q3
$1.32M Sell
39,670
-23,980
-38% -$848K 0.78% 41
2023
Q2
$2.33M Buy
63,650
+7,515
+13% +$293K 1.17% 23
2023
Q1
$2.29M Buy
56,135
+9,366
+20% +$405K 1.22% 23
2022
Q4
$2.4M Buy
+46,769
New +$2.24M 1.31% 23

Other funds holding PFE

3Chopt Investment Partners's PFE Position: Q2 2026 in Review

3Chopt Investment Partners reduced its Pfizer (PFE) stake by 10% in Q2 2026, selling an estimated $27.4K and leaving 9,420 shares worth $227K. The position accounts for 0.04% of the portfolio, ranked #230.

3Chopt Investment Partners first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.4M in Q4 2022. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 3Chopt Investment Partners held 9,420 shares of Pfizer worth $227K as of Q2 2026.
  • 3Chopt Investment Partners sold 1,047 Pfizer shares in Q2 2026, an estimated $27.4K.
  • Pfizer made up 0.04% of 3Chopt Investment Partners's portfolio in Q2 2026, its #230 holding.
  • 3Chopt Investment Partners first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • 3Chopt Investment Partners's Pfizer position peaked at $2.4M in Q4 2022.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.